STAT Plus: Pharmalittle: Mallinckrodt mulls restructuring as opioid trial nears; the next FDA commissioner will be …

Good morning, everyone, and how you today? We are doing just fine, thank you, since a cool breeze and shiny sun are enveloping the unusually placid Pharmalot campus. Our official mascot is curled up quietly nearby, the coffee kettle is approaching a boil, and a few happy birds are chirping nearby. Such serenity, however, can last only so long. In other words, it is time to get cracking. On that note, here are a few items of interest to help you get started on your own journey.

A federal judge reviewing a Justice Department decision to allow CVS Health (CVS) to merge with Aetna ruled that the agreement was in fact legal under antitrust law, Reuters tells us. The judge was examining a government plan to allow the merger on condition that Aetna sell its Medicare prescription drug plan business to WellCare Health Plans (WCG). Both deals closed. The judge initially balked at approving the conditions and insisted on hearing from critics. He complained, however, at the common practice of closing deals while a court review was still in process.

Continue to STAT Plus to read the full story…

Read Original Article: STAT Plus: Pharmalittle: Mallinckrodt mulls restructuring as opioid trial nears; the next FDA commissioner will be … »